Today, many biopharmaceutical companies are increasingly relying on outsourcing to save money, especially in countries with low labor costs. But safety operations, from clinical through post-marketing, require a higher level of expertise than many commonly outsourced functions, making it particularly challenging for biopharmaceutical companies to realize savings without putting quality and compliance at risk.

That was the challenge facing one of the world’s largest pharmaceutical companies when it sought a Functional Service Provider (FSP), commissioning Quintiles to create and manage a pharmacovigilance center of excellence in India. Learn more about this flexible, scalable operation that processes nearly 100,000 cases per year.